| Catalog_no |
ADMC0224 |
| Product_name |
Palbociclib (PD0332991 HCl) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
780.00/1120.00/1440.00 |
| Specificity |
Target: CDK. Fields: Palbociclib is an oral, small molecule cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, now in Phase 3 clinical development for advanced breast cancer. IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Dilution |
IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Purification |
>99% |
| Concentration |
靶点：CDK;IC50： 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
PD 0332991,PD-0332991 |
| Molecular Weight |
483.99 |
| Notes |
Palbociclib is an oral, small molecule cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, now in Phase 3 clinical development for advanced breast cancer. IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Instructions |
 查看与下载 |
